Drug recall

Galliprant (grapiprant tablets), 20mg, 90 tablets per bottle, (NDC: 86026-001-26), NADA: 141-455. Manufactured…

FDA recall event 78555 · Class II · Elanco Animal

Key facts

Event ID 78555
Recall numbers V-0082-2018, V-0083-2018
Recalling firm Elanco Animal
Product type Veterinary
Products Galliprant (grapiprant tablets), 20mg, 90 tablets per bottle, (NDC: 86026-001-26), NADA: 141-455. Manufactured for: Aratana Therapuetics, Inc., Leawood, KS 66211. Is potentially packaged in a 60mg/30…, Galliprant (grapiprant tablets), 60mg, 30 tablets per bottle, (NDC: 86026-002-23), NADA: 141-455. Manufactured for: Aratana Therapuetics, Inc., Leawood, KS 66211. ***Is potentially packaged in a…
Classification Class II
Status Terminated
Voluntary or mandated Firm Initiated
Reason for recall Incorrect labeling: Potential for bottles of product to be packaged in cartons that have incorrect strength listed.
Initiation date Nov 13, 2017
Report date Mar 28, 2018
Termination date Sep 13, 2018
City Greenfield
State IN
Country United States
FEI number 3008315190

At a glance

  • 1–9 Products in this recall
  • None FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls